Intracranial gliomas in neurofibromatosis type 1

Am J Med Genet. 1999 Mar 26;89(1):38-44. doi: 10.1002/(sici)1096-8628(19990326)89:1<38::aid-ajmg8>;2-m.


Optic pathway gliomas and brainstem gliomas are the predominant intracranial neoplasms associated with neurofibromatosis type 1 (NF1). Before the past 15 years, studies of optic pathway gliomas in NF1 were hampered by the inaccurate diagnosis of NF1, the unavailability of noninvasive neuroimaging techniques, and the frequent rendering of what would now be considered unnecessary, overly aggressive therapy. When studied systematically, these tumors behave in a much more benign fashion than their counterparts in children who do not have NF1. While they may cause symptoms in as many of 50% of cases, progression to the point where specific intervention is deemed necessary is unusual. Consequently, screening neuroimaging of asymptomatic patients is unwarranted. Because optic pathway tumors universally arise in children younger than 7 years of age, all such children should undergo yearly ophthalmologic evaluations and annual assessments of growth to monitor for signs of precocious puberty. Am. J. Med. Genet. (Semin. Med. Genet.) 89:38-44, 1999.

Publication types

  • Review

MeSH terms

  • Brain Neoplasms / diagnosis
  • Brain Neoplasms / epidemiology
  • Brain Neoplasms / physiopathology*
  • Brain Neoplasms / therapy
  • Child
  • Child, Preschool
  • Glioma / diagnosis
  • Glioma / epidemiology
  • Glioma / physiopathology*
  • Glioma / therapy
  • Humans
  • Incidence
  • Neurofibromatosis 1 / epidemiology
  • Neurofibromatosis 1 / pathology
  • Neurofibromatosis 1 / physiopathology*
  • Neurofibromatosis 1 / therapy
  • Puberty, Precocious / etiology